BC Week In Review | May 12, 2014
Company News

Pantec, Takeda deal

Pantec partnered with Takeda's New Frontier Science group to develop new treatments for inflammatory skin disease. The companies will use Pantec's Precise Laser EpidermAl SystEm (PLEASE) Professional laser device with topical drug formulations. Pantec said...
BC Week In Review | Nov 21, 2011
Company News

Pantec sales and marketing update

Pantec launched its Precise Laser EpidermAl SystEm (PLEASE) Professional laser device worldwide for transdermal drug delivery of large molecular weight drugs and aesthetic dermatology. Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery, Dermatology  ...
BC Week In Review | Feb 21, 2011
Company News

Catalent Pharma, Pantec deal

Catalent received exclusive, worldwide rights to Pantec's Lyopan technology. Lyopan is used to manufacture active pharmaceutical ingredients in fast-dissolve tablets for prescription and OTC products. Further terms were not disclosed. Catalent Pharma Solutions Inc. , Somerset,...
BC Week In Review | Jul 26, 2010
Company News

Pantec board of directors update

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Appointed: Manfred Asamer, CEO of Asamer Holding AG; and Werner Lanthaler, CEO of Evotec AG  ...
BC Week In Review | Jul 26, 2010
Financial News

Pantec completes venture financing

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Date completed: 7/20/10   Type: Venture financing   Raised: CHF20 million ($19.1 million)   Investor: StemCell Holding AG   Note: The offering comprises two financing...
BC Extra | Jul 21, 2010
Financial News

Pantec raises $19.1 million

Pantec Biosolutions AG (Ruggell, Liechtenstein) raised CHF20 million ($19.1 million) through two undisclosed financing rounds led by new investor StemCell Holding. Pantec is developing its P.L.E.A.S.E. drug delivery technology for needle-free and painless administration of...
BC Week In Review | Jun 7, 2010
Clinical News

PLEASE transdermal delivery device regulatory update

Pantec received CE Mark approval in Europe for its PLEASE transdermal delivery device. The device has the potential to deliver biologics or small molecules using intraepidermal microporation for dermatology and in general medicine applications. Pantec...
BC Week In Review | Mar 1, 2010
Clinical News

P: Phase I data

Data from a Phase I trial in 6 healthy male volunteers showed that treatment with Pantec's Painless Laser Epidermal System (P.L.E.A.S.E.) microporation device followed by a follicle stimulating hormone (FSH) patch achieved reproducible pharmacokinetics with...
BC Week In Review | Apr 27, 2009
Clinical News

P: Phase I data

Data from a German, pilot Phase I trial in 6 healthy male volunteers showed that treatment with Pantec's Painless Laser Epidermal System (P.L.E.A.S.E.) microporation device followed by a triptorelin patch produced serum levels of triptorelin...
BC Week In Review | May 19, 2008
Company News

Pantec board of directors update

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Appointed: Burkhard Feurstein, director of finance at Gamma Capital Partners AG; Michael Armbruester, founder of JB Commodities  ...
Items per page:
1 - 10 of 10
BC Week In Review | May 12, 2014
Company News

Pantec, Takeda deal

Pantec partnered with Takeda's New Frontier Science group to develop new treatments for inflammatory skin disease. The companies will use Pantec's Precise Laser EpidermAl SystEm (PLEASE) Professional laser device with topical drug formulations. Pantec said...
BC Week In Review | Nov 21, 2011
Company News

Pantec sales and marketing update

Pantec launched its Precise Laser EpidermAl SystEm (PLEASE) Professional laser device worldwide for transdermal drug delivery of large molecular weight drugs and aesthetic dermatology. Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery, Dermatology  ...
BC Week In Review | Feb 21, 2011
Company News

Catalent Pharma, Pantec deal

Catalent received exclusive, worldwide rights to Pantec's Lyopan technology. Lyopan is used to manufacture active pharmaceutical ingredients in fast-dissolve tablets for prescription and OTC products. Further terms were not disclosed. Catalent Pharma Solutions Inc. , Somerset,...
BC Week In Review | Jul 26, 2010
Company News

Pantec board of directors update

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Appointed: Manfred Asamer, CEO of Asamer Holding AG; and Werner Lanthaler, CEO of Evotec AG  ...
BC Week In Review | Jul 26, 2010
Financial News

Pantec completes venture financing

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Date completed: 7/20/10   Type: Venture financing   Raised: CHF20 million ($19.1 million)   Investor: StemCell Holding AG   Note: The offering comprises two financing...
BC Extra | Jul 21, 2010
Financial News

Pantec raises $19.1 million

Pantec Biosolutions AG (Ruggell, Liechtenstein) raised CHF20 million ($19.1 million) through two undisclosed financing rounds led by new investor StemCell Holding. Pantec is developing its P.L.E.A.S.E. drug delivery technology for needle-free and painless administration of...
BC Week In Review | Jun 7, 2010
Clinical News

PLEASE transdermal delivery device regulatory update

Pantec received CE Mark approval in Europe for its PLEASE transdermal delivery device. The device has the potential to deliver biologics or small molecules using intraepidermal microporation for dermatology and in general medicine applications. Pantec...
BC Week In Review | Mar 1, 2010
Clinical News

P: Phase I data

Data from a Phase I trial in 6 healthy male volunteers showed that treatment with Pantec's Painless Laser Epidermal System (P.L.E.A.S.E.) microporation device followed by a follicle stimulating hormone (FSH) patch achieved reproducible pharmacokinetics with...
BC Week In Review | Apr 27, 2009
Clinical News

P: Phase I data

Data from a German, pilot Phase I trial in 6 healthy male volunteers showed that treatment with Pantec's Painless Laser Epidermal System (P.L.E.A.S.E.) microporation device followed by a triptorelin patch produced serum levels of triptorelin...
BC Week In Review | May 19, 2008
Company News

Pantec board of directors update

Pantec Biosolutions AG , Ruggell, Liechtenstein   Business: Drug delivery   Appointed: Burkhard Feurstein, director of finance at Gamma Capital Partners AG; Michael Armbruester, founder of JB Commodities  ...
Items per page:
1 - 10 of 10